EurekAlert! -
23 Feb 2015 07:00
(Washington University School of Medicine) An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials headed by Mario Castro, MD, at Washington University School of Medicine in St. Louis.
Share this Article